Watch CBS News

New cancer vaccine boosts survival rate, Moderna says

There's promising news about a possible melanoma vaccine made by Moderna and Merck. Moderna said a small study showed the vaccine significantly lowered patients' risk of relapse or death. A larger study is planned for next year.
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.